2367 Stock Overview
An investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 6/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Giant Biogene Holding Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$49.85 |
| 52 Week High | HK$58.00 |
| 52 Week Low | HK$28.75 |
| Beta | 0.67 |
| 11 Month Change | -3.76% |
| 3 Month Change | 22.33% |
| 1 Year Change | 40.03% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 86.70% |
Recent News & Updates
Revenue Beat: Giant Biogene Holding Co., Ltd. Beat Analyst Estimates By 12%
Aug 21
Does Giant Biogene Holding (HKG:2367) Deserve A Spot On Your Watchlist?
Aug 09Recent updates
Revenue Beat: Giant Biogene Holding Co., Ltd. Beat Analyst Estimates By 12%
Aug 21Does Giant Biogene Holding (HKG:2367) Deserve A Spot On Your Watchlist?
Aug 09Giant Biogene Holding Co., Ltd.'s (HKG:2367) Popularity With Investors Is Clear
Jul 01Is Giant Biogene Holding Co., Ltd. (HKG:2367) Trading At A 32% Discount?
Apr 17Investors Interested In Giant Biogene Holding Co., Ltd.'s (HKG:2367) Earnings
Mar 28Giant Biogene Holding Co., Ltd. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next
Mar 27Do Giant Biogene Holding's (HKG:2367) Earnings Warrant Your Attention?
Dec 24A Look At The Intrinsic Value Of Giant Biogene Holding Co., Ltd. (HKG:2367)
Oct 30Giant Biogene Holding Co., Ltd.'s (HKG:2367) Share Price Matching Investor Opinion
Mar 28Shareholder Returns
| 2367 | HK Personal Products | HK Market | |
|---|---|---|---|
| 7D | -8.5% | -9.8% | -5.3% |
| 1Y | 40.0% | 14.9% | 11.3% |
Return vs Industry: 2367 exceeded the Hong Kong Personal Products industry which returned 14.9% over the past year.
Return vs Market: 2367 exceeded the Hong Kong Market which returned 11.3% over the past year.
Price Volatility
| 2367 volatility | |
|---|---|
| 2367 Average Weekly Movement | 7.7% |
| Personal Products Industry Average Movement | 7.1% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in HK Market | 19.1% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 2367 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2367's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 1,512 | Jianya Yan | www.xajuzi.com |
Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, and SKIGIN brands.
Giant Biogene Holding Co., Ltd. Fundamentals Summary
| 2367 fundamental statistics | |
|---|---|
| Market cap | HK$50.31b |
| Earnings (TTM) | HK$1.90b |
| Revenue (TTM) | HK$4.80b |
26.4x
P/E Ratio10.5x
P/S RatioIs 2367 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2367 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.46b |
| Cost of Revenue | CN¥769.50m |
| Gross Profit | CN¥3.69b |
| Other Expenses | CN¥1.92b |
| Earnings | CN¥1.77b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.75 |
| Gross Margin | 82.74% |
| Net Profit Margin | 39.65% |
| Debt/Equity Ratio | 0% |
How did 2367 perform over the long term?
See historical performance and comparison